Biovotec company was founded in Norway in 2014 by a team of passionate scientists, technologists and entrepreneurs with a proven execution track in biotech. The headquarter is located in Oslo, Norway.

With the ambition to bring its innovation to the international market, Biovotec has opened its first subsidiaries, in Dublin, Ireland and Sophia Antipolis, France. Biovotec is supported by Research partners across Europe. Biovotec has developed a scientific and medical network with both Key Opinion Leaders, healthcare professionals and healthcare institutions. The Company’s continuous development is supported by an experienced senior consultant team specialising in marketing, sales, health economics, regulation and compliance.

At the forefront of progress, Biovotec is engaged in transforming future wound healing and other skin applications by using innovation inspired by nature. The team has developed an innovative biomaterial, based on Purified Eggshell Membrane Protein, called PEP®. It meets the needs of patients and healthcare professionals:

  • Natural origin and Eco-friendly,
  • Innovative mechanism of action,
  • Reduced production cost for an affordable price.

The mission of Biovotec is to make advanced wound care treatment affordable and available for everybody, from the moment they need it. The scalable nature of the PEP® innovation opens up many applications such as wound healing and other promising applications related to skin.

Biovotec innovations have been recognized by renowned European awards and grants. The company participates regularly in international and national congresses dedicated to wound healing and is always in contact with the Scientific Health Societies. Biovotec scientific posters have been accepted and presented at main European congresses. To enhance PEP® technology-based innovation the Biovotec scientific team has organized scientific communications and symposia in collaboration with Key Opinion Leaders.

Biovotec’s Management team believes that PEP® based products have the potential to become the standard of care in the wound care market and other skin applications.

Henri-Pierre SUSO – CTO
Jevgenija PURANE – Marketing Advisor

Irene CLEARY – QA Manager
Connor HOLLYWOOD – Manufacturing Technician